Literature DB >> 7518149

FK 506 in small bowel transplant recipients: pharmacokinetics and dosing.

A Jain1, R Venkataramanan, J Lever, V Warty, K Abu-Elmagd, H Furukawa, J Reyes, B Nour, A Asrian, A Tzakis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7518149      PMCID: PMC2966309     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  8 in total

1.  Intravenous, oral pharmacokinetics, and oral dosing of FK 506 in small bowel transplant patients.

Authors:  A Jain; R Venkataramanan; S Todo; K Abu-Elmagd; J Fung; V Warty; A Tzakis; J Reyes; M Alessiani; T E Starzl
Journal:  Transplant Proc       Date:  1992-06       Impact factor: 1.066

2.  Pharmacokinetics of FK 506 in transplant patients.

Authors:  R Venkataramanan; A Jain; V S Warty; K Abu-Elmagd; M Alessiani; J Lever; A Krajak; J Flowers; S Mehta; S Zuckerman
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

3.  Comparative study of cyclosporine and FK 506 dosage requirements in adult and pediatric orthotopic liver transplant patients.

Authors:  A B Jain; J J Fung; A G Tzakis; R Venkataramanan; K Abu-Elmagd; M Alessiani; J Reyes; W Irish; V Warty; S Mehta
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

4.  Practical aspects of FK 506 analysis (Pittsburgh experience).

Authors:  V S Warty; R Venkataramanan; P Zendehrouh; S Mehta; T McKaveney; J Flowers; S Zuckerman; A Krajak; A Zeevi
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

5.  Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine.

Authors:  R Venkataramanan; A Jain; V W Warty; K Abu-Elmagd; H Furakawa; O Imventarza; J Fung; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

6.  Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506.

Authors:  A B Jain; J J Fung; S Todo; M Alessiani; S Takaya; K Abu-Elmagd; A Tzakis; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

7.  A highly sensitive method to assay FK-506 levels in plasma.

Authors:  K Tamura; M Kobayashi; K Hashimoto; K Kojima; K Nagase; K Iwasaki; T Kaizu; H Tanaka; M Niwa
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

8.  Intestinal transplantation in composite visceral grafts or alone.

Authors:  S Todo; A G Tzakis; K Abu-Elmagd; J Reyes; K Nakamura; A Casavilla; R Selby; B M Nour; H Wright; J J Fung
Journal:  Ann Surg       Date:  1992-09       Impact factor: 12.969

  8 in total
  3 in total

Review 1.  Pharmacokinetic considerations relating to tacrolimus dosing in the elderly.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

2.  The effect of tacrolimus (FK-506) on Japanese patients with refractory Crohn's disease.

Authors:  Hiroyuki Tamaki; Hiroshi Nakase; Minoru Matsuura; Satoko Inoue; Sakae Mikami; Satoru Ueno; Norimitsu Uza; Hiroshi Kitamura; Katsuhiro Kasahara; Tsutomu Chiba
Journal:  J Gastroenterol       Date:  2008-10-29       Impact factor: 7.527

Review 3.  Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.